Search Within

Joachim Yahalom

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (41)
  2. Meeting Abstract (38)
  3. Research Letter (2)
Groups
  1. Population Sciences Research Program (81)
  2. Radiation Oncology, Department of (81)
  3. Survivorship Research (81)
  4. Department of Medicine (70)
  5. Hematologic Malignancies, Division of (68)
  6. Center for Hematologic Malignancies (67)

More Groups

People
  1. Steven Horwitz (65)
  2. Andrew Zelenetz (61)
  3. Ariela Noy (45)
  4. Alison Moskowitz (44)
  5. David Straus (44)
  6. Paul Hamlin (44)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (4)
  5. 2021 (7)
  6. 2020 (7)

More Years

Publications
  1. Blood (25)
  2. Journal of Clinical Oncology (13)
  3. Journal of the National Comprehensive Cancer Network (9)
  4. Hematological Oncology (6)
  5. British Journal of Haematology (4)
  6. Blood Advances (3)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. American Society of Clinical Oncology (13)
  3. Harborside Press (9)
  4. Wiley Blackwell (7)
  5. Elsevier Inc. (5)
  6. John Wiley & Sons (4)

More Publishers

Results (81)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation
    Journal Article

    Correa, D. D.; Braun, E.; Kryza-Lacombe, M.; Ho, K. W.; Reiner, A. S.; Panageas, K. S.; Yahalom, J.; Sauter, C. S.; Abrey, L. E.; DeAngelis, L. M.; more...
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens
    Meeting Abstract

    Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Treatment of vulvar mycosis fungoides tumors with localized radiotherapy
    Journal Article

    Geller, S.; Pitter, K.; Moskowitz, A.; Horwitz, S. M.; Yahalom, J.; Myskowski, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017
    Journal Article

    Wierda, W. G.; Zelenetz, A. D.; Gordon, L. I.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Byrd, J. C.; Caimi, P.; Fayad, L. E.; more...
    Journal of the National Comprehensive Cancer Network (2017)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save